Confidence has been shaken in Oxford BioMedica following news that its chief executive has stepped down just one month after …
Oxford BioMedica has unanimously rejected two takeover offers from GeneThera, saying the US firm was "not a credible bidder". The …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

